zotepine
Sign in to saveZotepine is an atypical antipsychotic drug indicated for acute and chronic schizophrenia. It has been used in Germany since 1990 (although it has been discontinued in Germany) and Japan since 1982.
Research
319 papers- Zotepine for schizophrenia.The Cochrane database of systematic reviews · 2000
- Zotepine for schizophrenia.The Cochrane database of systematic reviews · 2006
- Zotepine versus other atypical antipsychotics for schizophrenia.The Cochrane database of systematic reviews · 2010
- Safety evaluation of zotepine for the treatment of schizophrenia.Expert opinion on drug safety · 2010
- Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.Lancet (London, England) · 2019
via PubMed
Article
10 sectionsContents
- Medical uses
- Side effects
- Pharmacology
- Pharmacodynamics
- Synthesis
- Society and culture
- Brand names
- See also
- References
- Further reading
Zotepine is an atypical antipsychotic drug indicated for acute and chronic schizophrenia. It has been used in Germany since 1990 (although it has been discontinued in Germany) and Japan since 1982.
Zotepine is not approved for use in the United States, United Kingdom, Australia, Canada or New Zealand.
Connections
Categories
Alpha-2 blockersAtypical antipsychoticsChloroarenesDibenzothiepinesDimethylamino compoundsDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs with non-standard legal statusECHA InfoCard ID from WikidataEnol ethersM1 receptor antagonistsM2 receptor antagonists